Information about Rpo Nucleogenesis
My details
*
*
*

Rpo Nucleogenesis (SRL)

BE 0782.980.238

Bassebeekstraat 39, 9031 Gent

Company information

Status
Active

Enterprise number

BE0782.980.238

VAT liability
Yes
Established
08-03-2022
Last balance sheet year
2023
Company size
Micro 0 FTE
Principal activity
Manufacture of basic pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Rpo Nucleogenesis

2023
Profit/Loss € 2,885
Equity € 20,385
Gross margin € 8,231

Publications from Rpo Nucleogenesis

Date Publication
09-05-2025 Resignations - Appointments (NL)
05-01-2023 Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
11-10-2022 Resignations - Appointments (NL)
10-03-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Rpo Nucleogenesis?
The VAT number of Rpo Nucleogenesis is BE 0782.980.238.
Wat is the PEPPOL ID of Rpo Nucleogenesis?
There is no information available about the PEPPOL ID of Rpo Nucleogenesis or the company is not yet registered on the PEPPOL network.
When was Rpo Nucleogenesis founded?
Rpo Nucleogenesis was founded on 08-03-2022.
What is the address of Rpo Nucleogenesis?
The current registered office of Rpo Nucleogenesis is located at Bassebeekstraat 39, 9031 Gent.
When was the last time Rpo Nucleogenesis filed their annual financial statements?
The most recent financial statements of Rpo Nucleogenesis were filed on 15-07-2024.
How many employees does Rpo Nucleogenesis have?
There are currently no employees working at Rpo Nucleogenesis or no workforce information is available.
What is the annual turnover of Rpo Nucleogenesis?
At the time of its most recent financial statements, Rpo Nucleogenesis did not publish any turnover figures. Rpo Nucleogenesis reported a gross margin of €8,231.04.

Sources